ABIDEMI OLADELE: Open Payments
NPI 1780324335 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 23 payments from 4 companies in 2025. Trend: 2023 $489 · 2024 $996 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $287 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $122 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| Neos Therapeutics, LP | 1 | $22 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Adzenys XR-ODT.
Industry payments across TX — which companies pay providers there.
